Hagar Kalinski
Inventor
Stats
- 20 US patents issued
- 47 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 20 US Patents Issued
- 47 US Applications Filed
- 225 Total Citation Count
- Oct 25, 2024 Most Recent Filing
- May 25, 2006 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
NITTO DENKO TECHNICAL CORPORATION | 2
| 2011
|
QUARK PHARMACEUTICALS, INC. | 1
6 6 1 4 9 6 2 6 3 1 | 2006
2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 |
NITTO DENKO CORPORATION | 2
2 4 3 2 | 2010
2011 2012 2014 2015 |
WASHINGTON UNIVERSITY | 2
| 2015
|
UNIVERSITY OF WASHINGTON | 2
| 2012
|
Inventor Addresses
Address | Duration |
---|---|
RISHON-LE-ZION, IL | Oct 13, 11 - Oct 13, 11 |
Rishon Le Zion, IL | Jul 28, 16 - Jan 11, 18 |
Rishon Le-Zion, IL | Jul 21, 11 - Feb 05, 19 |
Rishon Lezion, IL | Jan 11, 24 - Apr 10, 25 |
Rishon le Zion, IL | Nov 21, 17 - Sep 24, 19 |
Rishon le-Zion, IL | Feb 05, 19 - Feb 05, 19 |
Rishon-Ie-Zion, IL | May 05, 11 - May 12, 11 |
Rishon-Le-Zion, IL | Nov 06, 14 - Oct 24, 17 |
Rishon-le-Zion, IL | Apr 28, 09 - Sep 22, 20 |
Rishon-le-zion, IL | Jun 18, 09 - Jun 18, 09 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 29 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 15 |
C07H: | SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS | 26 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2025/0114,453 | 2025 | METHODS FOR ENHANCING THERAPEUTIC EFFICACY OF ISOLATED CELLS FOR CELL THERAPY | 0 |
2024/0010,977 | 2024 | METHODS FOR ENHANCING THERAPEUTIC EFFICACY OF ISOLATED CELLS FOR CELL THERAPY | 0 |
10781449 | 2020 | Double-stranded oligonucleotide molecules targeting p53 and methods of use thereof | 0 |
10421962 | 2019 | Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof | 0 |
2019/0040,385 | 2019 | DOUBLE-STRANDED OLIGONUCLEOTIDE MOLECULES TARGETING P53 AND METHODS OF USE THEREOF | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.